Roles of aldosterone in vascular calcification: An update

European Journal of Pharmacology

Volumn 786, Issue , 2016, Pages 186-193

  Gao, Jingwei ^a,b   Zhang, Kun ^a,b   Chen, Jie ^a,b   Wang, Mong Heng ^c   Wang, Jingfeng ^a,b   Liu, Pinming ^a,b   Huang, Hui ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology   (China)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Aldosterone; Genomic mechanisms; Non genomic mechanisms; Vascular calcification; Vascular smooth muscle cells

Indexed keywords

ALDOSTERONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BINDING AFFINITY; BLOOD VESSEL CALCIFICATION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; HORMONE ACTION; HUMAN; INFLAMMATION; NONHUMAN; OSTEOINDUCTIVE SIGNALING; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; GENETICS; METABOLISM; PATHOLOGY;

ALDOSTERONE; ANIMALS; HUMANS; VASCULAR CALCIFICATION;

EID: 84974539590     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2016.05.030     Document Type: Review

References (82)

1. M. Abedin, J. Lim, T.B. Tang, D. Park, L.L. Demer, and Y. Tintut N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways Circ. Res. 98 2006 727 729
2. H. Adel, A. Taye, and M.M. Khalifa Spironolactone improves endothelial dysfunction in streptozotocin-induced diabetic rats Naunyn Schmiede. Arch. Pharmacol. 387 2014 1187 1197
3. R. Alzamora, L.R. Brown, and B.J. Harvey Direct binding and activation of protein kinase C isoforms by aldosterone and 17beta-estradiol Mol. Endocrinol. 21 2007 2637 2650
4. L. Bessueille, and D. Magne Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes Cell Mol. Life Sci. 72 2015 2475 2489
5. E.R. Blasi, R. Rocha, A.E. Rudolph, E.A.G. Blomme, M.L. Polly, and E.G. McMahon Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats Kidney Int. 63 2003 1791 1800
6. C.H. Byon, A. Javed, Q. Dai, J.C. Kappes, T.L. Clemens, V.M. Darley-Usmar, J.M. McDonald, and Y. Chen Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling J. Biol. Chem. 283 2008 15319 15327
7. G.E. Callera, R.M. Touyz, R.C. Tostes, A. Yogi, Y. He, S. Malkinson, and E.L. Schiffrin Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src Hypertension 45 2005 773 779
8. M. Caprio, B.G. Newfell, A. la Sala, W. Baur, A. Fabbri, G. Rosano, M.E. Mendelsohn, and I.Z. Jaffe Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion Circ. Res. 102 2008 1359 1367
9. C. Catena, G. Colussi, F. Nait, F. Martinis, F. Pezzutto, and L.A. Sechi Aldosterone and the heart: still an unresolved issue? Front. Endocrinol. 5 2014 168
10. M. Christ, C. Meyer, K. Sippel, and M. Wehling Rapid aldosterone signaling in vascular smooth muscle cells: involvement of phospholipase C, diacylglycerol and protein kinase C α Biochem Biophys. Res. Commun. 213 1995 123 129
11. G.D.M. Collett, A.P. Sage, J.P. Kirton, M.Y. Alexander, A.P. Gilmore, and A.E. Canfield Axl/phosphatidylinositol 3-kinase signaling inhibits mineral deposition by vascular smooth muscle cells Circ. Res. 100 2007 502 509
12. R. Dooley, B.J. Harvey, and W. Thomas Non-genomic actions of aldosterone: from receptors and signals to membrane targets Mol. Cell Endocrinol. 350 2012 223 234
13. A.M. Dorrance Interfering with mineralocorticoid receptor activation: the past, present, and future F1000Prime Rep. 6 2014 61
14. W.B. Ershler, and E.T. Keller Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty Annu Rev. Med 51 2000 245 270
15. E. Falkenstein, H.C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple actions of steroid hormones - A focus on rapid, nongenomic effects Pharmacol. Rev. 52 2000 513 555
16. S.S. Fischer, D.S. Kempe, C.B. Leibrock, R. Rexhepaj, B. Siraskar, K.M. Boini, and T.F. Achermann Hyperaldosteronism in Klotho-deficient mice Am. J. Physiol. Ren. Physiol. 299 2010 F1171 F1177
17. U. Forstermann, and H. Li Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling Br. J. Pharmacol. 164 2011 213 223
18. C.S. Fox, C.Y. Guo, M.G. Larson, R.S. Vasan, H. Parise, C.J. O'Donnell, R.B. D'Agostino Sr., J.F. Keaney Jr., and E.J. Benjamin Relations of inflammation and novel risk factors to valvular calcification Am. J. Cardiol 97 2006 1502 1505
19. G.-X. Fu, C.-C. Xu, Y. Zhong, D.-L. Zhu, and P.-J. Gao Aldosterone-induced osteopontin expression in vascular smooth muscle cells involves MR, ERK, and p38 MAPK Endocrine 42 2012 676 683
20. M. Fujita, T. Minamino, H. Asanuma, S. Sanada, A. Hirata, M. Wakeno, M. Myoishi, H. Okuda, A. Ogai, K. Okada, O. Tsukamoto, H. Koyama, M. Hori, and M. Kitakaze Aldosterone nongenomically worsens ischemia via protein kinase C-dependent pathways in hypoperfused canine hearts Hypertension 46 2005 113 117
21. R. Gros, Q. Ding, B. Liu, J. Chorazyczewski, and R.D. Feldman Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation Am. J. Physiol. Cell Physiol. 304 2013 C532 C540
22. R. Gros, Q.M. Ding, L.A. Sklar, E.E. Prossnitz, J.B. Arterburn, J. Chorazyczewski, and R.D. Feldman GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone Hypertension 57 2011 442 451
23. C. Grossmann, A.W. Krug, R. Freudinger, S. Mildenberger, K. Voelker, and M. Gekle Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter Am J Physiol-Endocrinol Metab. 292 2007 E1790 E1800
24. H. Hitomi, H. Kiyomoto, A. Nishiyama, T. Hara, K. Moriwaki, K. Kaifu, G. Ihara, Y. Fujita, T. Ugawa, and M. Kohno Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells Hypertension 50 2007 750 755
25. M.C. Hu, M. Shi, J. Zhang, H. Quinones, C. Griffith, M. Kuro-o, and O.W. Moe Klotho deficiency causes vascular calcification in chronic kidney disease J. Am. Soc. Nephrol. 22 2010 124 136
26. K. Iijima, Y. Ito, B.K. Son, M. Akishita, and Y. Ouchi Pravastatin and olmesartan synergistically ameliorate renal failure-induced vascular calcification J. Atheroscler. Thromb. 21 2014 917 929
27. I.Z. Jaffe, and M.E. Mendelsohn Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells Circ. Res. 96 2005 643 650
28. I.Z. Jaffe, Y. Tintut, B.G. Newfell, L.L. Demer, and M.E. Mendelsohn Mineralocorticoid receptor activation promotes vascular cell calcification Arterioscler. Thromb. Vasc. Biol. 27 2007 799 805
29. B. Jian, N., N, Q.Y. Li, E.R. Mohler III, and R.J. Levy Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis Ann. Thorac. Surg. 75 2003 457 466
30. R.C. Johnson, J.A. Leopold, and J. Loscalzo Vascular calcification: pathobiological mechanisms and clinical implications Circ. Res. 99 2006 1044 1059
31. Y. Kanno, T. Into, C.J. Lowenstein, and K. Matsushita Nitric oxide regulates vascular calcification by interfering with TGF- signalling Cardiovasc. Res. 77 2008 221 230
32. W. Karwowski, B. Naumnik, M. Szczepanski, and M. Mysliwiec The mechanism of vascular calcification - a systematic review Med Sci. Monit. 18 2012 Ra1 Ra11
33. F. Lang, E. Ritz, I. Alesutan, and J. Voelkl Impact of aldosterone on osteoinductive signaling and vascular calcification Nephron Physiol. 128 2014 40 45
34. F. Lang, E. Ritz, J. Voelkl, and I. Alesutan Vascular calcification - is aldosterone a culprit? Nephrol. Dial. Transpl. 28 2013 1080 1084
35. C. Le Moellic, A. Ouvrard-Pascaud, C. Capurro, F. Cluzeaud, M. Fay, F. Jaisser, N. Farman, and M. Blot-Chabaud Early nongenomic events in aldosterone action in renal collecting duct cells: PKCalpha activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response J. Am. Soc. Nephrol. 15 2004 1145 1160
36. P. Lencel, P. Hardouin, and D. Magne Do cytokines induce vascular calcification by the mere stimulation of TNAP activity? Med. Hypotheses 75 2010 517 521
37. O. Leonard, J. Spaak, and D. Goldsmith Regression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence Br. J. Clin. Pharmacol. 76 2013 560 572
38. J.A. Leopold, A. Dam, B.A. Maron, A.W. Scribner, R. Liao, D.E. Handy, R.C. Stanton, B. Pitt, and J. Loscalzo Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity Nat. Med. 13 2007 189 197
39. H. Li, S. Horke, and U. Forstermann Vascular oxidative stress, nitric oxide and atherosclerosis Atherosclerosis 237 2014 208 219
40. X. Li, H.Y. Yang, and C.M. Giachelli Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification Circ. Res. 98 2006 905 912
41. L.Z. Liao, Q. Zhou, Y. Song, W.K. Wu, H.M. Yu, S. Wang, Y.L. Chen, M.H. Ye, and L.H. Lu Ceramide mediates Ox-LDL-induced human vascular smooth muscle cell calcification via p38 mitogen-activated protein kinase signaling PLoS One 8 2013 e82379
42. J. Liu, K.L. Ma, M. Gao, C.X. Wang, J. Ni, Y. Zhang, X.L. Zhang, H. Liu, Y.L. Wang, and B.C. Liu Inflammation disrupts the LDL receptor pathway and accelerates the progression of vascular calcification in ESRD patients PLoS One 7 2012 e47217
43. R.M. Losel, E. Falkenstein, M. Feuring, A. Schultz, H.C. Tillmann, K. Rossol-Haseroth, and M. Wehling Nongenomic steroid action: controversies, questions, and answers Physiol. Rev. 83 2003 965 1016
44. A. McCurley, and I.Z. Jaffe Mineralocorticoid receptors in vascular function and disease Mol. Cell Endocrinol. 350 2012 256 265
45. A. McCurley, A. McGraw, D. Pruthi, and I.Z. Jaffe Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease Pflug. Arch. 465 2013 1661 1670
46. L. Michea, A.M. Delpiano, C. Hitschfeld, L. Lobos, S. Lavandero, and E.T. Marusic Eplerenone blocks nongenomic effects of aldosterone on the Na+/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels Endocrinology 146 2005 973 980
47. J.D. Miller, Y. Chu, R.M. Brooks, W.E. Richenbacher, R. Pena-Silva, and D.D. Heistad Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans J. Am. Coll. Cardiol. 52 2008 843 850
48. I. Nadra, J.C. Mason, P. Philippidis, O. Florey, C.D. Smythe, G.M. McCarthy, R.C. Landis, and D.O. Haskard Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ. Res. 96 2005 1248 1256
49. K. Nishiwaki-Yasuda, A. Suzuki, A. Kakita, S. Sekiguchi, S. Asano, K. Nishii, S. Nagao, Y. Oiso, and M. Itoh Vasopressin stimulates Na-dependent phosphate transport and calcification in rat aortic smooth muscle cells Endocr. J. 54 2007 103 112
50. K. Nitta, T. Akiba, and H. Nihei Aldosterone blockade and vascular calcification in hemodialysis patients Am. J. Med 115 2003 250
51. M. Pacurari, R. Kafoury, P.B. Tchounwou, and K. Ndebele The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling Int. J. Inflamm. 2014 2014 689360
52. G. Pearson, F. Robinson, T.B. Gibson, B.E. Xu, M. Karandikar, K. Berman, and M.H. Cobb Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions Endocr. Rev. 22 2001 153 183
53. T. Polepalle, S. Moogala, S. Boggarapu, D.S. Pesala, and F.B. Palagi Acute phase proteins and their role in periodontitis: a review J. Clin. Diagn. Res. 9 2015 ZE01 ZE05
54. D. Proudfoot, J.N. Skepper, L. Hegyi, M.R. Bennett, C.M. Shanahan, and P.L. Weissberg Apoptosis regulates human vascular calcification in vitro - evidence for initiation of vascular calcification by apoptotic bodies Circ. Res. 87 2000 1055 1062
55. Q. Pu, M.F. Neves, A. Virdis, R.M. Touyz, and E.L. Schiffrin Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling Hypertension 42 2003 49 55
56. Y. Rautureau, P. Paradis, and E.L. Schiffrin Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells Steroids 76 2011 834 839
57. R.J. Rennenberg, A.G. Kessels, L.J. Schurgers, J.M. van Engelshoven, P.W. de Leeuw, and A.A. Kroon Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vascular Health Risk Manag. 5 2009 185 197
58. R. Rocha, A.E. Rudolph, G.E. Frierdich, D.A. Nachowiak, B.K. Kekec, E.A.G. Blomme, E.G. McMahon, and J.A. Delyani Aldosterone induces a vascular inflammatory phenotype in the rat heart Am. J. Physiol.-Heart C. 283 2002 H1802 H1810
59. A.P. Sage, Y. Tintut, and L.L. Demer Regulatory mechanisms in vascular calcification Nat. Rev. Cardiol. 7 2010 528 536
60. D. Sanz-Rosa, E. Cediel, N. de las Heras, M. Miana, G. Balfagon, V. Lahera, and V. Cachofeiro Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: role of the NFkappaB/IkappaB system J. Hypertens. 23 2005 1167 1172
61. G. Schlieper, L. Schurgers, V. Brandenburg, C. Reutelingsperger, and J. Floege Vascular calcification in chronic kidney disease: an update Nephrol. Dial. Transpl. 31 2016 31 39
62. D.M. Shavelle, R. Katz, J. Takasu, J.A. Lima, N.S. Jenny, M.J. Budoff, and K.D. O'Brien Soluble intercellular adhesion molecule-1 (sICAM-1) and aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis (MESA) J. Heart Valve Dis. 17 2008 388 395
63. Y. Shi, B.D. Gou, Y.L. Shi, T.L. Zhang, and K. Wang Lanthanum chloride suppresses hydrogen peroxide-enhanced calcification in rat calcifying vascular cells Biometals 22 2009 317 327
64. B.K. Son, K. Kozaki, K. Iijima, M. Eto, T. Nakano, M. Akishita, and Y. Ouchi Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells Eur. J. Pharmacol. 556 2007 1 8
65. J.H. Son, Y.C. Cho, I.Y. Sung, I.R. Kim, B.S. Park, and Y.D. Kim Melatonin promotes osteoblast differentiation and mineralization of MC3T3-E1 cells under hypoxic conditions through activation of PKD/p38 pathways J. Pineal Res. 57 2014 385 392
66. M.Y. Speer, H.Y. Yang, T. Brabb, E. Leaf, A. Look, W.L. Lin, A. Frutkin, D. Dichek, and C.M. Giachelli Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries Circ. Res. 104 2009 733 741
67. Y. Tada, S. Yano, T. Yamaguchi, K. Okazaki, N. Ogawa, M. Morita, and T. Sugimoto Advanced glycation end products-induced vascular calcification is mediated by oxidative stress: functional roles of NAD(P)H-oxidase Horm. Metab. Res. 45 2013 267 272
68. N. Tatsumoto, S. Yamada, M. Tokumoto, M. Eriguchi, H. Noguchi, K. Torisu, K. Tsuruya, and T. Kitazono Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification Am. J. Physiol. Ren. Physiol. 309 2015 F967 F979
69. A. Taye, and H. Morawietz Spironolactone inhibits NADPH oxidase-induced oxidative stress and enhances eNOS in human endothelial cells Iran. J. Pharm. Res. 10 2011 329 337
70. W. Thomas, V. McEneaney, and J. Harvey Aldosterone-stimulated PKC signalling cascades: from receptor to effector Biochem. Soc. Trans. 35 2007 1049 1051
71. A. Virdis, M.F. Neves, F. Amiri, E. Viel, R.M. Touyz, and E.L. Schiffrin Spironolactone improves angiotensin-induced vascular changes and oxidative stress Hypertension 40 2002 504 510
72. J. Voelkl, I. Alesutan, C.B. Leibrock, L. Quintanilla-Martinez, V. Kuhn, M. Feger, S. Mia, M.S. Ahmed, K.P. Rosenblatt, O.M. Kuro, and F. Lang Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice J. Clin. Investig. 123 2013 812 822
73. D. Wang, Q. Zeng, R. Song, L. Ao, D.A. Fullerton, and X. Meng Ligation of ICAM-1 on human aortic valve interstitial cells induces the osteogenic response: A critical role of the Notch1-NF-kappaB pathway in BMP-2 expression Biochim. Biophys. Acta 1843 2014 2744 2753
74. K.E. Watson, K. Bostrom, R. Ravindranath, T. Lam, B. Norton, and L.L. Demer TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify J. Clin. Invest 93 1994 2106 2113
75. H.Y. Wei, X.H. Mi, L. Ji, L.C. Yang, Q.J. Xia, Y.Q. Wei, I. Miyamori, and C.Y. Fan Protein kinase C-delta is involved in induction of NOX1 gene expression by aldosterone in rat vascular smooth muscle cells Biochemistry 75 2010 304 309
76. Y. Wei, A.T. Whaley-Connell, J. Habibi, J. Rehmer, N. Rehmer, K. Patel, M. Hayden, V. DeMarco, C.M. Ferrario, J.A. Ibdah, and J.R. Sowers Mineralocorticoid receptor antagonism attenuates vascular apoptosis and injury via rescuing protein kinase B activation Hypertension 53 2009 158 165
77. J.S. Williams Evolving research in nongenomic actions of aldosterone Curr. Opin. Endocrinol. Diabetes Obes. 20 2013 198 203
78. M. Wu, C. Rementer, and C.M. Giachelli Vascular calcification: an update on mechanisms and challenges in treatment Calcif. Tissue Int. 93 2013 365 373
79. S.Y. Wu, Y.R. Yu, Y. Cai, L.X. Jia, X. Wang, C.S. Xiao, C.S. Tang, and Y.F. Qi Endogenous aldosterone is involved in vascular calcification in rat Exp. Biol. Med. 237 2012 31 37
80. T.T. Yin, J. Patel, F. Parhami, and L.L. Demer Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway Circulation 102 2000 2636 2642
81. G. Zhao, M.J. Xu, M.M. Zhao, X.Y. Dai, W. Kong, G.M. Wilson, Y. Guan, C.Y. Wang, and X. Wang Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression Kidney Int. 82 2012 34 44
82. C.J. Zhu, Q.Q. Wang, J.L. Zhou, H.Z. Liu, F. Hua, H.Z. Yang, and Z.W. Hu The mineralocorticoid receptor-p38MAPK-NFkappaB or ERK-Sp1 signal pathways mediate aldosterone-stimulated inflammatory and profibrotic responses in rat vascular smooth muscle cells Acta Pharmacol. Sin. 33 2012 873 878